Neurometrix is a medical device company establishing a new standard of care through the design development and sale of proprietary products used to diagnose neuropathies. Neuropathies are diseases of the peripheral nerves and parts of the spine that frequently are caused by or associated with diabetes low back pain and carpal tunnel syndrome as well as other clinical disorders. NeuroMetrix Inc. has a market cap of $21.35 million; its shares were traded at around $1.19 with and P/S ratio of 0.69.
Recent Trades of NeuroMetrix Inc. by CEO:
- Buy: President & CEO Shai Gozani bought 100,000 shares of NURO stock on 02/27/2009 at the average price of $1.3; the price of the stock has decreased by 8.46% since.